Van Naarden Jacob
EVP &Pres., Lilly Oncology | EVP &Pres., Loxo@lilly | EVP And CEO Loxo@lilly +1 more
1 company
Van Naarden Jacob is an EVP &Pres., Lilly Oncology at ELI LILLY & Co. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $23.3M based on current market prices.
Holdings by Company
LLYAug 13, 2025
Current Shares20.6K
Value$23.30M
Net Activity+1.0K
Bought: 1.0KSold: 0
Transaction History
Showing 1 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | LLY Eli Lilly & Co | EVP &Pres., Lilly Oncology | Buy | 1,000 | $647.36 | $647,360.00 | +5.1% | +49.7% | - |